[eDisclosure Notice] KOSPI - 28th

◆Orient Bio = Decided on a third-party allotment paid-in capital increase worth 11.7 billion KRW.

◆Orient Bio = Decided to acquire 3,774,092 shares of affiliate Orient Electronics for approximately 6.7 billion KRW.

◆Kolon = Decided to lend 15 billion KRW to affiliate Kolon Life Science.

◆Daehan Petrochemical = Q2 operating profit preliminarily estimated at 72.4 billion KRW, turning to profit compared to the previous year. Sales for the same period increased by 8.6% to 439.5 billion KRW.

◆Korea Aerospace Industries = Q2 operating profit preliminarily estimated at 61.2 billion KRW, down 47.5% year-on-year. Sales for the same period decreased by 10.5% to 721.1 billion KRW.

◆S-1 Corporation = Q2 operating profit preliminarily estimated at 64.6 billion KRW, up 9.18% year-on-year. Sales for the same period increased by 2.5% to 559 billion KRW.

◆Samsung Biologics = Signed a contract for pharmaceutical contract manufacturing worth 179.5 billion KRW with a US-based pharmaceutical company.

◆Samsung Engineering = Q2 operating profit preliminarily estimated at 85.8 billion KRW, down 14.2% year-on-year. Sales for the same period increased by 3% to 1,674.3 billion KRW.